Hepatocellular carcinoma (HCC) usually arises in the context of a chronically damaged liver.
Liver functional estimation is of paramount importance in clinical decision making. The Child …

Over the past decade, immune checkpoint blockade (ICB) therapy has revolutionized the
outlook for oncology with significant and sustained improvement in the overall patient …

Background Immune checkpoint inhibitors (ICIs) are promising agents for unresectable
hepatocellular carcinoma (uHCC), but lack effective biomarker to predict outcomes. The gut …

Immunotherapy is a promising approach to treating various types of cancers, including
hepatocellular carcinoma (HCC). While single immunotherapy drugs show limited …

Importance Immune checkpoint inhibitors (ICIs) are increasingly used in patients with
advanced hepatocellular carcinoma (HCC). However, data on ICI therapy in patients with …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality in Taiwan.
The Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan had …

Background Immunotherapy with immune checkpoint inhibitor (ICI) is a promising treatment
for unresectable hepatocellular carcinoma (HCC). However, whether ICIs would have the …

Objective We conducted the first meta-analysis to identify the predictive significance of
baseline blood biomarkers (such as neutrophil to lymphocyte ratio (NLR), early alpha …

Background. We aimed to investigate the efficacy and safety of atezolizumab plus
bevacizumab therapy in patients with unresectable hepatocellular carcinoma (u-HCC) …

Immune checkpoint inhibitors (ICI) have shown positive results in patients with
hepatocellular carcinoma (HCC). As liver function contributes to prognosis, its precise …